glp 1 and fatty liver Resolution of NASH hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis Transforming Liver & Metabolic Health

All products are developed according to the same philosophy: genuine dry liposomes, produced in our own facility, without compromising on quality

Total saponins from panax japonicus attenuate acute alcoholic liver oxidative stress and hepatosteatosis by P62-related nrf2 pathway and ampk-acc/ppar Axis in vivo and in vitro

A review of recent literature shows that dietary RSs, as prebiotics, contribute to the restoration of a healthy gut microbiota structure, beneficial for maintaining gut barrier integrity and mucosal immune tolerance

While weight loss can occur on GLP-1 medications without exercise , adding resistance training helps preserve lean muscle mass and improves metabolic health outcomes beyond what medication alone achieves